Plantar Fasciitis Treatment Market is expected to reach US$ 1242.35 Mn. at a CAGR of 4.40% during the forecast period 2030.Plantar Fasciitis Treatment Market Overview:
Plantar fasciitis is a type of repetitive strain injury that affects runners, hikers, and walkers, as well as practically everyone who works standing for a living, such as cashiers, especially on hard surfaces. Plantar fasciitis' multifactorial aetiology has resulted in a large increase in the number of sufferers, as well as a solid foundation for the creation of firms that treat the ailment.To know about the Research Methodology :- Request Free Sample Report
Plantar Fasciitis Treatment Market Dynamics:
The rising prevalence of obesity is the main factor driving the market growth. The global market is being driven by an increase in the use of orthotics, as well as an increase in the number of cases of plantar fasciitis. A wide range of treatments is emerging as a viable ally in the fight against severe heel pain caused by plantar fasciitis, broadening the possibility of growth for stakeholders. Plantar fasciitis affects an estimated 2 million people worldwide each year, according to the National Centre for Health Statistics (NCHS). Furthermore, the expanding obesity population is contributing to the market's growth, as fat persons are more likely to acquire plantar fasciitis. Body mass index (BMI) was strongly associated with plantar fasciitis, according to a study published in The Journal of Pain by the National Centre for Complementary and Integrative Health (NCCIH). Those with a BMI of 30 or more (1.48 %) were 5 times more likely to have plantar fasciitis than those with a BMI of less than 25. (0.29%). Though a sedentary, inactive lifestyle isn't the primary cause of plantar fasciitis, it does raise the likelihood of the condition. Furthermore, the shift in people's lifestyles toward sedentary activities, combined with their quickly changing eating habits, has resulted in a considerable increase in obesity cases. Furthermore, the growing elderly population, technological developments, and the availability of various treatment choices are all driving the plantar fasciitis treatment market forward. The high cost of therapy and lack of understanding about the plantar fasciitis ailment, on the other hand, are impeding the plantar fasciitis treatment market's growth. The report has profiled eighteen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.Plantar Fasciitis Treatment Market Segment Analysis:
The Global Plantar Fasciitis Treatment Market is segmented on the basis of Treatment Type and End-Users. Based on Treatment Type, the Orthotic Devices segment is expected to dominate during the forecast period. Orthotic devices, commonly known as orthoses, are braces that aid in the support of weakening muscles while jogging and walking. They also help to improve comfort and delay the progression of contractures (tightened muscles or tendons that become shorter over time). Wearing orthotic devices at any time of day or night is possible. The sort of orthotic device to be used depends on the patient's problem. Ankle-foot orthoses and knee-ankle-foot orthoses are the two most common types of orthotic devices. The prevalence of plantar fasciitis in United States adults was highest in women (1.19 %) compared to men (0.47 %), in population aged between 45 to 64 (1.33 %) versus population aged 18 to 44 (0.53 %).Plantar Fasciitis Treatment Market Regional Insights:
North America is expected to hold a dominant market share during the forecast period. North America has a sizable market share in the global market, which is projected to continue throughout the forecast period. Plantar fasciitis diagnosis and prevalence rates are steadily increasing in the region. Furthermore, the rise in the number of obese people in the United States, as well as changing lifestyles, are pushing the plantar fasciitis treatment market in the United States. According to the National Clinical Studies (NCT) registry, there are approximately 6 recruiting clinical trials in various stages of development for the treatment of Plantar Fasciitis in the United States as of June 18, 2020. The report also helps in understanding the Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.Plantar Fasciitis Treatment Market Scope: Inquire before buying
Global Plantar Fasciitis Treatment Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US$ 919.05 Mn. Forecast Period 2024 to 2030 CAGR: 4.40% Market Size in 2030 : US$ 1242.35 Mn. Segments Covered: by Treatment Type Pharmacological Treatment Orthotic devices Shockwave Therapy Surgery Other Treatment Types by End-Users Hospitals Orthopedic Clinics Other End-Users Plantar Fasciitis Treatment Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Plantar Fasciitis Treatment Market, Key Players are
1. Hanger, Inc., 2. Bayer Group (Dr. Scholl's), 3. A. Algeo Limited, 4. Bauerfeind AG, 5. Superfeet Worldwide, Inc., 6. Ottobock SE & Co. KGaA (Ottobock Holding), 7. Pfizer, Inc., 8. Sanofi, G 9. GlaxoSmithKline plc. 10. Recover Sports Medicine 11. Shapecrunch Technology Pvt Ltd 12. 3M 13. UPMC 14. OrthoBethesda 15. APOTHECARY PRODUCTS, LLC 16. Ellis & Badenhausen 17. SYNXSOLE PTY LTD. 18. Revance Therapeutics, Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Market? Ans: North America region holds the highest share in 2023. 2. What is the growth rate of Global Plantar Fasciitis Treatment Market? Ans: The Global Plantar Fasciitis Treatment Market is growing at a CAGR of 4.40% during forecasting period 2024-2030. 3. What is scope of the Global Plantar Fasciitis Treatment market report? Ans: Global Plantar Fasciitis Treatment Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Plantar Fasciitis Treatment market? Ans: The important key players in the Global Plantar Fasciitis Treatment Market are – Hanger, Inc.,, Bayer Group (Dr. Scholl's),, A. Algeo Limited,, Bauerfeind AG,, Superfeet Worldwide, Inc.,, Ottobock SE & Co. KGaA (Ottobock Holding),, Pfizer, Inc.,, Sanofi, G, GlaxoSmithKline plc., Recover Sports Medicine, Shapecrunch Technology Pvt Ltd, 3M, UPMC, OrthoBethesda, APOTHECARY PRODUCTS, LLC, Ellis & Badenhausen, SYNXSOLE PTY LTD., Revance Therapeutics, and Inc.. 5. What is the study period of this market? Ans: The Global Plantar Fasciitis Treatment Market is studied from 2023 to 2030.
1. Plantar Fasciitis Treatment Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Plantar Fasciitis Treatment Market: Dynamics 2.1. Plantar Fasciitis Treatment Market Trends by Region 2.1.1. North America Plantar Fasciitis Treatment Market Trends 2.1.2. Europe Plantar Fasciitis Treatment Market Trends 2.1.3. Asia Pacific Plantar Fasciitis Treatment Market Trends 2.1.4. Middle East and Africa Plantar Fasciitis Treatment Market Trends 2.1.5. South America Plantar Fasciitis Treatment Market Trends 2.2. Plantar Fasciitis Treatment Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Plantar Fasciitis Treatment Market Drivers 2.2.1.2. North America Plantar Fasciitis Treatment Market Restraints 2.2.1.3. North America Plantar Fasciitis Treatment Market Opportunities 2.2.1.4. North America Plantar Fasciitis Treatment Market Challenges 2.2.2. Europe 2.2.2.1. Europe Plantar Fasciitis Treatment Market Drivers 2.2.2.2. Europe Plantar Fasciitis Treatment Market Restraints 2.2.2.3. Europe Plantar Fasciitis Treatment Market Opportunities 2.2.2.4. Europe Plantar Fasciitis Treatment Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Plantar Fasciitis Treatment Market Drivers 2.2.3.2. Asia Pacific Plantar Fasciitis Treatment Market Restraints 2.2.3.3. Asia Pacific Plantar Fasciitis Treatment Market Opportunities 2.2.3.4. Asia Pacific Plantar Fasciitis Treatment Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Plantar Fasciitis Treatment Market Drivers 2.2.4.2. Middle East and Africa Plantar Fasciitis Treatment Market Restraints 2.2.4.3. Middle East and Africa Plantar Fasciitis Treatment Market Opportunities 2.2.4.4. Middle East and Africa Plantar Fasciitis Treatment Market Challenges 2.2.5. South America 2.2.5.1. South America Plantar Fasciitis Treatment Market Drivers 2.2.5.2. South America Plantar Fasciitis Treatment Market Restraints 2.2.5.3. South America Plantar Fasciitis Treatment Market Opportunities 2.2.5.4. South America Plantar Fasciitis Treatment Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Plantar Fasciitis Treatment Industry 2.8. Analysis of Government Schemes and Initiatives For Plantar Fasciitis Treatment Industry 2.9. Plantar Fasciitis Treatment Market Trade Analysis 2.10. The Global Pandemic Impact on Plantar Fasciitis Treatment Market 3. Plantar Fasciitis Treatment Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 3.1.1. Pharmacological Treatment 3.1.2. Orthotic devices 3.1.3. Shockwave Therapy 3.1.4. Surgery 3.1.5. Other Treatment Types 3.2. Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 3.2.1. Hospitals 3.2.2. Orthopedic Clinics 3.2.3. Other End-Users 3.3. Plantar Fasciitis Treatment Market Size and Forecast, by Region (2023-2030) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America Plantar Fasciitis Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 4.1.1. Pharmacological Treatment 4.1.2. Orthotic devices 4.1.3. Shockwave Therapy 4.1.4. Surgery 4.1.5. Other Treatment Types 4.2. North America Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 4.2.1. Hospitals 4.2.2. Orthopedic Clinics 4.2.3. Other End-Users 4.3. North America Plantar Fasciitis Treatment Market Size and Forecast, by Country (2023-2030) 4.3.1. United States 4.3.1.1. United States Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 4.3.1.1.1. Pharmacological Treatment 4.3.1.1.2. Orthotic devices 4.3.1.1.3. Shockwave Therapy 4.3.1.1.4. Surgery 4.3.1.1.5. Other Treatment Types 4.3.1.2. United States Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 4.3.1.2.1. Hospitals 4.3.1.2.2. Orthopedic Clinics 4.3.1.2.3. Other End-Users 4.3.2. Canada 4.3.2.1. Canada Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 4.3.2.1.1. Pharmacological Treatment 4.3.2.1.2. Orthotic devices 4.3.2.1.3. Shockwave Therapy 4.3.2.1.4. Surgery 4.3.2.1.5. Other Treatment Types 4.3.2.2. Canada Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 4.3.2.2.1. Hospitals 4.3.2.2.2. Orthopedic Clinics 4.3.2.2.3. Other End-Users 4.3.3. Mexico 4.3.3.1. Mexico Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 4.3.3.1.1. Pharmacological Treatment 4.3.3.1.2. Orthotic devices 4.3.3.1.3. Shockwave Therapy 4.3.3.1.4. Surgery 4.3.3.1.5. Other Treatment Types 4.3.3.2. Mexico Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 4.3.3.2.1. Hospitals 4.3.3.2.2. Orthopedic Clinics 4.3.3.2.3. Other End-Users 5. Europe Plantar Fasciitis Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.2. Europe Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 5.3. Europe Plantar Fasciitis Treatment Market Size and Forecast, by Country (2023-2030) 5.3.1. United Kingdom 5.3.1.1. United Kingdom Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.3.1.2. United Kingdom Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 5.3.2. France 5.3.2.1. France Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.3.2.2. France Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 5.3.3. Germany 5.3.3.1. Germany Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.3.3.2. Germany Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 5.3.4. Italy 5.3.4.1. Italy Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.3.4.2. Italy Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 5.3.5. Spain 5.3.5.1. Spain Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.3.5.2. Spain Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 5.3.6. Sweden 5.3.6.1. Sweden Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.3.6.2. Sweden Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 5.3.7. Austria 5.3.7.1. Austria Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.3.7.2. Austria Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 5.3.8.2. Rest of Europe Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6. Asia Pacific Plantar Fasciitis Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.2. Asia Pacific Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3. Asia Pacific Plantar Fasciitis Treatment Market Size and Forecast, by Country (2023-2030) 6.3.1. China 6.3.1.1. China Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.1.2. China Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.2. S Korea 6.3.2.1. S Korea Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.2.2. S Korea Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.3. Japan 6.3.3.1. Japan Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.3.2. Japan Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.4. India 6.3.4.1. India Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.4.2. India Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.5. Australia 6.3.5.1. Australia Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.5.2. Australia Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.6. Indonesia 6.3.6.1. Indonesia Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.6.2. Indonesia Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.7. Malaysia 6.3.7.1. Malaysia Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.7.2. Malaysia Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.8. Vietnam 6.3.8.1. Vietnam Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.8.2. Vietnam Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.9. Taiwan 6.3.9.1. Taiwan Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.9.2. Taiwan Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 6.3.10.2. Rest of Asia Pacific Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 7. Middle East and Africa Plantar Fasciitis Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 7.2. Middle East and Africa Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 7.3. Middle East and Africa Plantar Fasciitis Treatment Market Size and Forecast, by Country (2023-2030) 7.3.1. South Africa 7.3.1.1. South Africa Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 7.3.1.2. South Africa Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 7.3.2. GCC 7.3.2.1. GCC Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 7.3.2.2. GCC Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 7.3.3. Nigeria 7.3.3.1. Nigeria Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 7.3.3.2. Nigeria Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 7.3.4.2. Rest of ME&A Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 8. South America Plantar Fasciitis Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 8.2. South America Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 8.3. South America Plantar Fasciitis Treatment Market Size and Forecast, by Country (2023-2030) 8.3.1. Brazil 8.3.1.1. Brazil Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 8.3.1.2. Brazil Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 8.3.2. Argentina 8.3.2.1. Argentina Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 8.3.2.2. Argentina Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Plantar Fasciitis Treatment Market Size and Forecast, by Treatment Type (2023-2030) 8.3.3.2. Rest Of South America Plantar Fasciitis Treatment Market Size and Forecast, by End User (2023-2030) 9. Global Plantar Fasciitis Treatment Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Plantar Fasciitis Treatment Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Hanger, Inc., 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Bayer Group (Dr. Scholl's), 10.3. A. Algeo Limited, 10.4. Bauerfeind AG, 10.5. Superfeet Worldwide, Inc., 10.6. Ottobock SE & Co. KGaA (Ottobock Holding), 10.7. Pfizer, Inc., 10.8. Sanofi, G 10.9. GlaxoSmithKline plc. 10.10. Recover Sports Medicine 10.11. Shapecrunch Technology Pvt Ltd 10.12. 3M 10.13. UPMC 10.14. OrthoBethesda 10.15. APOTHECARY PRODUCTS, LLC 10.16. Ellis & Badenhausen 10.17. SYNXSOLE PTY LTD. 10.18. Revance Therapeutics, Inc. 11. Key Findings 12. Industry Recommendations 13. Plantar Fasciitis Treatment Market: Research Methodology 14. Terms and Glossary